Review



population-based pbpk simulator simcyp® version 15  (Simcyp)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Simcyp population-based pbpk simulator simcyp® version 15
    Population Based Pbpk Simulator Simcyp® Version 15, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/population-based+pbpk+simulator+simcyp%C2%AE+version+15/simcyp+v19/pm30068519-144-56-58
    Average 90 stars, based on 1 article reviews
    population-based pbpk simulator simcyp® version 15 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Inhibition:

    Article Title: Physiologically Based Pharmacokinetic Model of Itraconazole and Two of Its Metabolites to Improve the Predictions and the Mechanistic Understanding of CYP3A4 Drug-Drug Interactions.
    Article Snippet: For inhibition parameters (fu,mic2), where protein concentration was similar to measured fu,mic conditions, no correction was deemed necessary based on the binding profile of OH-ITZ (Tran et al., 2002). at A SPE T Journals on A ugust 6, 2018 dm d.aspetjournals.org D ow nloaded from DMD#81364 13 Simulations using PBPK modeling The Simcyp® (version 15) population-based PBPK simulator (Simcyp® Ltd, Certara, Sheffield, UK) was used to simulate the PK of itraconazole, and its metabolites (OH-ITZ and keto-ITZ) and relevant DDI in virtual healthy volunteers.

    Protein Concentration:

    Article Title: Physiologically Based Pharmacokinetic Model of Itraconazole and Two of Its Metabolites to Improve the Predictions and the Mechanistic Understanding of CYP3A4 Drug-Drug Interactions.
    Article Snippet: For inhibition parameters (fu,mic2), where protein concentration was similar to measured fu,mic conditions, no correction was deemed necessary based on the binding profile of OH-ITZ (Tran et al., 2002). at A SPE T Journals on A ugust 6, 2018 dm d.aspetjournals.org D ow nloaded from DMD#81364 13 Simulations using PBPK modeling The Simcyp® (version 15) population-based PBPK simulator (Simcyp® Ltd, Certara, Sheffield, UK) was used to simulate the PK of itraconazole, and its metabolites (OH-ITZ and keto-ITZ) and relevant DDI in virtual healthy volunteers.

    Binding Assay:

    Article Title: Physiologically Based Pharmacokinetic Model of Itraconazole and Two of Its Metabolites to Improve the Predictions and the Mechanistic Understanding of CYP3A4 Drug-Drug Interactions.
    Article Snippet: For inhibition parameters (fu,mic2), where protein concentration was similar to measured fu,mic conditions, no correction was deemed necessary based on the binding profile of OH-ITZ (Tran et al., 2002). at A SPE T Journals on A ugust 6, 2018 dm d.aspetjournals.org D ow nloaded from DMD#81364 13 Simulations using PBPK modeling The Simcyp® (version 15) population-based PBPK simulator (Simcyp® Ltd, Certara, Sheffield, UK) was used to simulate the PK of itraconazole, and its metabolites (OH-ITZ and keto-ITZ) and relevant DDI in virtual healthy volunteers.



    Similar Products

    90
    Simcyp population-based pbpk simulator simcyp® version 15
    Population Based Pbpk Simulator Simcyp® Version 15, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/population-based+pbpk+simulator+simcyp%C2%AE+version+15/simcyp+v19/pm30068519-144-56-58
    Average 90 stars, based on 1 article reviews
    population-based pbpk simulator simcyp® version 15 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results